title: Phase transitions in human IgG solutions.
abstract: Protein condensations, such as crystallization, liquid-liquid phase separation, aggregation, and gelation, have been observed in concentrated antibody solutions under various solution conditions. While most IgG antibodies are quite soluble, a few outliers can undergo condensation under physiological conditions. Condensation of IgGs can cause serious consequences in some human diseases and in biopharmaceutical formulations. The phase transitions underlying protein condensations in concentrated IgG solutions is also of fundamental interest for the understanding of the phase behavior of non-spherical protein molecules. Due to the high solubility of generic IgGs, the phase behavior of IgG solutions has not yet been well studied. In this work, we present an experimental approach to study IgG solutions in which the phase transitions are hidden below the freezing point of the solution. Using this method, we have investigated liquid-liquid phase separation of six human myeloma IgGs and two recombinant pharmaceutical human IgGs. We have also studied the relation between crystallization and liquid-liquid phase separation of two human cryoglobulin IgGs. Our experimental results reveal several important features of the generic phase behavior of IgG solutions: (1) the shape of the coexistence curve is similar for all IgGs but quite different from that of quasi-spherical proteins; (2) all IgGs have critical points located at roughly the same protein concentration at ~100 mg/ml while their critical temperatures vary significantly; and (3) the liquid-liquid phase separation in IgG solutions is metastable with respect to crystallization. These features of phase behavior of IgG solutions reflect the fact that all IgGs have nearly identical molecular geometry but quite diverse net inter-protein interaction energies. This work provides a foundation for further experimental and theoretical studies of the phase behavior of generic IgGs as well as outliers with large propensity to condense. The investigation of the phase diagram of IgG solutions is of great importance for the understanding of immunoglobulin deposition diseases as well as for the understanding of the colloidal stability of IgG pharmaceutical formulations.
authors.affiliation: Materials Processing Center, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
authors.forename: Ying
authors.initials: Y
authors.lastname: Wang
authors.forename: Aleksey
authors.initials: A
authors.lastname: Lomakin
authors.forename: Ramil F
authors.initials: RF
authors.lastname: Latypov
authors.forename: Jacob P
authors.initials: JP
authors.lastname: Laubach
authors.forename: Teru
authors.initials: T
authors.lastname: Hideshima
authors.forename: Paul G
authors.initials: PG
authors.lastname: Richardson
authors.forename: Nikhil C
authors.initials: NC
authors.lastname: Munshi
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: Anderson
authors.forename: George B
authors.initials: GB
authors.lastname: Benedek
mesh_terms: D018360:Crystallography, X-Ray; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000737:chemistry* / Q000235:genetics; D008958:Models, Molecular; D009101:Multiple Myeloma / Q000097:blood / Q000737:chemistry*; D044367:Phase Transition; D012996:Solutions; D013696:Temperature
chemical_list: D007074:Immunoglobulin G; D012996:Solutions